Search research articles
Contact Us
Filters
Showing results (1-10 of 151) with videos related to
Page
of 16
Sort By:
Structure (London, England : 1993)
|
April 9, 2020
Breaking the Enigma Code of Angiotensin II Type 2 Receptor Signaling
Anastasiia Sadybekov, Vsevolod Katritch
Trends in Pharmacological Sciences
|
September 10, 2011
GPCR agonist binding revealed by modeling and crystallography
Vsevolod Katritch, Ruben Abagyan
NPJ Drug Discovery
|
December 4, 2025
Navigating structure-based drug discovery with emerging innovations in physics- and knowledge-based approaches
Jordy Homing Lam, Vsevolod Katritch
Nature
|
April 26, 2023
Computational approaches streamlining drug discovery
Anastasiia V Sadybekov, Vsevolod Katritch
Handbook of Experimental Pharmacology
|
May 4, 2021
Structural Characterization of KOR Inactive and Active States for 3D Pharmacology and Drug Discovery
Saheem A Zaidi, Vsevolod Katritch
Clinical and Translational Medicine
|
April 4, 2022
It all clicks together: In silico drug discovery becoming mainstream
Antonina L Nazarova, Vsevolod Katritch
Current Opinion in Structural Biology
|
March 26, 2019
Computational design for thermostabilization of GPCRs
Petr Popov, Igor Kozlovskii, Vsevolod Katritch
Neuropharmacology
|
July 20, 2010
Structure based prediction of subtype-selectivity for adenosine receptor antagonists
Vsevolod Katritch, Irina Kufareva, Ruben Abagyan
Journal of Computational Chemistry
|
December 24, 2002
ICFF: a new method to incorporate implicit flexibility into an internal coordinate force field
Vsevolod Katritch, Maxim Totrov, Ruben Abagyan
Methods in Molecular Biology (Clifton, N.J.)
|
February 11, 2012
Ligand-guided receptor optimization
Vsevolod Katritch, Manuel Rueda, Ruben Abagyan
Page
of 16
Search research articles
Search
Showing results (1-10 of 151) with videos related to
Sort By:
Page
of 16
Structure (London, England : 1993)
|
April 9, 2020
Breaking the Enigma Code of Angiotensin II Type 2 Receptor Signaling
Anastasiia Sadybekov, Vsevolod Katritch
Trends in Pharmacological Sciences
|
September 10, 2011
GPCR agonist binding revealed by modeling and crystallography
Vsevolod Katritch, Ruben Abagyan
NPJ Drug Discovery
|
December 4, 2025
Navigating structure-based drug discovery with emerging innovations in physics- and knowledge-based approaches
Jordy Homing Lam, Vsevolod Katritch
Nature
|
April 26, 2023
Computational approaches streamlining drug discovery
Anastasiia V Sadybekov, Vsevolod Katritch
Handbook of Experimental Pharmacology
|
May 4, 2021
Structural Characterization of KOR Inactive and Active States for 3D Pharmacology and Drug Discovery
Saheem A Zaidi, Vsevolod Katritch
Clinical and Translational Medicine
|
April 4, 2022
It all clicks together: In silico drug discovery becoming mainstream
Antonina L Nazarova, Vsevolod Katritch
Current Opinion in Structural Biology
|
March 26, 2019
Computational design for thermostabilization of GPCRs
Petr Popov, Igor Kozlovskii, Vsevolod Katritch
Neuropharmacology
|
July 20, 2010
Structure based prediction of subtype-selectivity for adenosine receptor antagonists
Vsevolod Katritch, Irina Kufareva, Ruben Abagyan
Journal of Computational Chemistry
|
December 24, 2002
ICFF: a new method to incorporate implicit flexibility into an internal coordinate force field
Vsevolod Katritch, Maxim Totrov, Ruben Abagyan
Methods in Molecular Biology (Clifton, N.J.)
|
February 11, 2012
Ligand-guided receptor optimization
Vsevolod Katritch, Manuel Rueda, Ruben Abagyan
Page
of 16